Franklin Resources Portfolio holdings
Franklin Resources is the parent of the Franklin Templeton fund brands, founded in 1947 by Rupert H. Johnson Sr., a Wall Street retail broker who named it after Benjamin Franklin. Rupert Sr.'s son Charles B. Johnson became president and chief executive in 1957, and the company went public in 1971. In 1992 Franklin bought Templeton, Galbraith & Hansberger, which was then owned by mutual fund pioneer Sir John Templeton, and in 2020 it bought Legg Mason. Its fund brands include Franklin for bond funds, Templeton for international funds and Mutual Series for value funds. Its funds include Templeton Growth, opened in 1954, Mutual Shares, opened in 1949, and Mutual Discovery, opened in 1992. It launched its first ETFs in 2013 and a bitcoin and ether ETF in 2025, and in August 2026 Franklin Resources renamed itself Franklin Templeton, Inc. to match its brand.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$563M |
| 2 |
Nokia
NOK
|
+$505M |
| 3 |
RAI
Reynolds American Inc
RAI
|
+$499M |
| 4 |
Macy's
M
|
+$456M |
| 5 |
EMC CORPORATION
EMC
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TLM
TALISMAN ENERGY INC
TLM
|
+$1.08B |
| 2 |
LO
LORILLARD INC COM STK
LO
|
+$977M |
| 3 |
Cigna
CI
|
+$409M |
| 4 |
Target
TGT
|
+$387M |
| 5 |
GE Aerospace
GE
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.62% |
| 2 | Financials | 13.6% |
| 3 | Technology | 11.34% |
| 4 | Energy | 10.05% |
| 5 | Industrials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.89T
| $4.29B | 1.95% |
97,260,096
-2,676,590
| -3% | -$122M |
2013 Q2
8 quarters
|
|
2
Pfizer
PFE
$166B
| $2.99B | 1.36% |
94,074,827
-1,010,296
| -1% | -$32.9M |
2013 Q2
8 quarters
|
|
3
Teva Pharmaceutical Industries Limited
TEVA
$50.9B
| $2.96B | 1.34% |
50,121,400
-4,925,570
| -9% | -$304M |
2013 Q2
8 quarters
|
|
4
Medtronic
MDT
$130B
| $2.89B | 1.31% |
38,983,141
-777,659
| -2% | -$59.4M |
2013 Q2
8 quarters
|
|
5
Eli Lilly
LLY
$1.28T
| $2.64B | 1.2% |
31,674,129
+2,303,049
| +8% | +$175M |
2013 Q2
8 quarters
|
|
6
Merck
MRK
$364B
| $2.62B | 1.19% |
48,296,819
-2,875,817
| -6% | -$161M |
2013 Q2
8 quarters
|
|
7
JPMorgan Chase
JPM
$914B
| $2.57B | 1.17% |
37,977,468
-260,098
| -0.7% | -$17M |
2013 Q2
8 quarters
|
|
8
Apple
AAPL
$5.17T
| $2.54B | 1.15% |
81,001,492
-5,940,720
| -7% | -$190M |
2013 Q2
8 quarters
|
|
9
Chevron
CVX
$425B
| $2.3B | 1.04% |
23,828,218
+482,171
| +2% | +$50.6M |
2013 Q2
8 quarters
|
|
|
10
Target
TGT
$73.2B
| $2.22B | 1.01% |
27,239,927
-4,784,280
| -15% | -$387M |
2013 Q2
8 quarters
|
|
|
RDS.A
11
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.19B | 1% |
40,558,283
+6,323,629
| +18% | +$362M |
2013 Q2
8 quarters
|
|
12
Citigroup
C
$206B
| $2.07B | 0.94% |
37,456,907
-3,376,449
| -8% | -$184M |
2013 Q2
8 quarters
|
|
13
PepsiCo
PEP
$196B
| $2.03B | 0.92% |
21,709,430
+43,599
| +0.2% | +$4.17M |
2013 Q2
8 quarters
|
|
14
General Motors
GM
$73.5B
| $2.02B | 0.92% |
60,743,714
+2,398,915
| +4% | +$85.6M |
2013 Q2
8 quarters
|
|
15
American International
AIG
$42.8B
| $1.83B | 0.83% |
29,562,792
+47,008
| +0.2% | +$2.78M |
2013 Q2
8 quarters
|
|
|
16
GE Aerospace
GE
$347B
| $1.75B | 0.79% |
13,745,346
-2,902,313
| -17% | -$376M |
2013 Q2
8 quarters
|
|
17
Cisco
CSCO
$402B
| $1.73B | 0.79% |
63,067,284
-5,237,936
| -8% | -$150M |
2013 Q2
8 quarters
|
|
18
Amgen
AMGN
$254B
| $1.63B | 0.74% |
10,615,891
-36,963
| -0.3% | -$5.92M |
2013 Q2
8 quarters
|
|
19
CVS Health
CVS
$115B
| $1.61B | 0.73% |
15,341,330
-184,199
| -1% | -$18.8M |
2013 Q2
8 quarters
|
|
20
Gilead Sciences
GILD
$210B
| $1.6B | 0.73% |
13,693,250
+1,187,858
| +9% | +$130M |
2013 Q2
8 quarters
|
|
21
DuPont de Nemours
DD
$20.5B
| $1.54B | 0.7% |
11,878,175
-180,880
| -1% | -$23.4M |
2013 Q2
8 quarters
|
|
|
AGN
22
DELISTED
Allergan plc
AGN
| $1.5B | 0.68% |
4,939,107
+38,687
| +0.8% | +$11.5M |
2013 Q2
8 quarters
|
|
23
Johnson & Johnson
JNJ
$684B
| $1.48B | 0.67% |
15,181,005
+361,602
| +2% | +$36.2M |
2013 Q2
8 quarters
|
|
24
PG&E
PCG
$28.6B
| $1.47B | 0.67% |
29,972,000
-473,690
| -2% | -$24.6M |
2013 Q2
8 quarters
|
|
25
Southern Company
SO
$108B
| $1.45B | 0.66% |
34,539,136
+3,604,150
| +12% | +$157M |
2013 Q2
8 quarters
|
|
Similar funds
Franklin Resources's Q2 2015 Portfolio in Review
As of Q2 2015, Franklin Resources held 1,677 positions worth $220B, down 0.11% from $221B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Franklin Resources's Q2 2015 filing shows 107 new, 565 increased, 652 reduced and 79 closed positions. Its largest new stake was Nokia: 69,288,354 shares worth $475M. The largest sale was TALISMAN ENERGY INC, an estimated $1.08B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Financials and Technology.
- Franklin Resources's largest Q2 2015 buy was Nokia: 69,288,354 shares worth $475M.
- Franklin Resources added most to ExxonMobil in Q2 2015, an estimated $563M increase.
- Franklin Resources's biggest Q2 2015 reduction was Cigna, cutting an estimated $409M.
- Franklin Resources fully exited TALISMAN ENERGY INC in Q2 2015, selling an estimated $1.08B.
- Franklin Resources's ten largest holdings make up 13% of its $220B portfolio in Q2 2015.
- Franklin Resources opened 107 new positions and closed 79 in Q2 2015.
- Franklin Resources's portfolio value fell 0.11% quarter-over-quarter to $220B.
Based on Franklin Resources's 13F filing for Q2 2015, filed 12 Aug 2015.